PMI to Push Smoke-Free Agenda in U.S. with Technovation Event

Event summary

  • PMI’s ‘Technovation’ platform will launch in the U.S. on April 14th, bringing together industry leaders to discuss a smoke-free future.
  • PMI U.S. has invested heavily in domestic manufacturing, operating facilities in Aurora, Colorado; Owensboro, Kentucky; and Wilson, North Carolina, and employing over 3,000 people.
  • ZYN, a nicotine pouch, is PMI’s leading smoke-free product in the U.S. and the first to receive FDA authorization.
  • PMI has invested over $16 billion since 2008 in developing and commercializing smoke-free products, now used by 43 million consumers globally.

The big picture

PMI’s Technovation event signals an intensified effort to shape the U.S. nicotine market, leveraging science and policy influence. The company’s significant investments in U.S. manufacturing and workforce development suggest a long-term commitment to the domestic market, but also expose it to economic and regulatory risks. With $16 billion invested since 2008, PMI’s success hinges on navigating a complex regulatory environment and convincing consumers to adopt smoke-free alternatives.

What we're watching

Regulatory Scrutiny
The FDA’s stance on modified risk tobacco product authorizations (MRTPs) will be crucial for PMI’s continued market access and expansion, particularly as public health concerns around nicotine persist.
Consumer Adoption
Whether PMI can sustain the current growth rate of its smoke-free products will depend on successfully shifting consumer behavior away from traditional cigarettes and overcoming misperceptions about nicotine.
Competitive Landscape
The emergence of new competitors and alternative nicotine delivery systems could erode PMI’s market share and necessitate further innovation to maintain its leadership position.

Related topics

Market Share